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Pertussis is a highly contagious infection caused by the Gram-negative 
bacteria Bordetella pertussis and B. parapertussis. It is a vaccine-
preventable disease mainly affecting the respiratory tract. Whole-
cell pertussis vaccines were introduced in the 1950s and resulted 
in a marked decrease in the incidence of pertussis worldwide. The 
reappearance of pertussis was predicted and has been documented 
mainly in developed countries since the 1990s.[1] There are several 
explanations for this resurgence, the most prominent being waning 
immunity in the older child and adult population, shorter and 
lower vaccine-induced immunity after changeover from the whole-
cell to the acellular pertussis vaccine, and pathogen adaptation 
of the B.  pertussis populations.[2] The Expanded Programme on 
Immunisation in South Africa (SA) changed from using whole-cell 
to acellular pertussis vaccine in 2009. Despite the fact that pertussis 
is a notifiable disease in this country, data on the burden of disease 
before and after the changeover are extremely limited. This study 
was designed to describe the extent of the problem of pertussis in a 
hospital setting over a 7-year period in children in Bloemfontein, SA.
Methods
Study design
This was a retrospective descriptive hospital-based study during the 
period April 2008 - March 2015 (84 months). Only children whose 
diagnosis was confirmed with a pertussis polymerase chain reaction 
(PCR) test were included.
Study location
National District, Pelonomi and Universitas hospitals (primary-, 
secondary- and tertiary-level healthcare institutions, respectively) 
form the cluster of public sector hospitals in Bloemfontein associated 
with the academic complex of the Faculty of Health Sciences of the 
University of the Free State.
Data collection and inclusion criteria
Doctors working in the above settings, at their discretion, took nasal 
or nasopharyngeal swabs from a child if the clinical picture was 
suggestive of pertussis, such as a cough lasting >14 days, post-tussive 
vomiting, coughing spells, apnoea episodes or if the full blood count 
showed a total white cell count ≥20.0 × 109/L. Standard-sized Dacron 
swabs were used and the specimens were sent to the National Health 
Laboratory Service (NHLS) laboratory in Johannesburg, SA. PCR 
testing specific for insertion sequences IS481 (B. pertussis) and IS1001 
(B. parapertussis) was done using a commercial kit. Tests to exclude B. 
holmesii and B. bronchiseptica were not done. On receipt of a positive 
pertussis PCR result, 1 - 2 weeks after the swab had been taken, clinical 
data were collected retrospectively from the clinical records.
Children diagnosed with pertussis were grouped by age in the 
report. These groups were selected in relation to timing of vaccination 
in SA, which occurs at 6, 10 and 14 weeks of age with a booster 
at 18 months of age, as follows: neonates (age ≤4 weeks), infants 
(>4 - 6 weeks) before the first vaccination, infants (>6 - 10  weeks) 
before the second vaccination, infants (>10 - 14 weeks) before the 
third vaccination, infants (>14 - 18 weeks) 4 weeks after the third 
vaccination, infants/toddlers (>18 weeks - 18 months), and children 
(>18 months) after the booster vaccination dose.
Statistical analysis
Data were analysed using the SAS system, version 9.3 (Statistical 
Analysis Software Institute, USA). Results were summarised by means, 
medians, standard deviations (numerical variables), frequencies 
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and percentages (categorical variables). 
Asso ciations between categorical variables 
were analysed using relative risks (RRs) 
with 95% confidence intervals (CIs), χ2 and 
Fisher’s exact tests. Subgroup comparisons of 
numer ical variables were done using Mann-
Whitney tests with 95% CIs for median 
differences.
Ethical considerations
Approval for the study was granted by the 
Ethics Committee of the Faculty of Health 
Sciences of the University of the Free State 
(ECUFS NR 143/2008). Permission to collect 
the data for the study was given by the 
clinical heads of Pelonomi, National District 
and Universitas hospitals. Parental consent 
was waived, as this was a retrospective study 
based on hospital records.
Results
Laboratory reports
A total of 1 259 swabs from the public health 
sector in Bloemfontein were recorded as 
received at the NHLS laboratory in Johan-
nesburg during the 7-year period from April 
2008 onwards. Of these, 183 (14.5%) con-
firmed pertussis. The temporal distribution 
of the pertussis cases is shown in Fig. 1, with 
an increase in cases at the beginning of 2008 
and 2010 and an obvious epidemic peak 
during 2011 when 96/183 cases (52.5%) were 
diagnosed. The results are presented against 
a backdrop of the laboratory-confirmed per-
tussis cases in SA recorded by the National 
Institute of Communicable Diseases (NICD) 
in Johannesburg for this time period (Fig. 1 
and Table 1).
The organism was identified as B. pertus­
sis in 173/183 cases (94.5%) and B. para­
pertussis in 8/183 (4.4%), and the PCR test 
was positive for both species in 2 cases.
The age distribution of the children 
is shown in Table 2. The median age was 
12.9  weeks (interquartile range (IQR) 7.6 - 
39.6). Infants <18 weeks of age made up 57.4% 
of cases. There was an overall non-significant 
female preponderance of cases (53.6%; 
p=0.337). This was significant in children 
aged <18  weeks compared with those aged 
≥18 weeks (<18 weeks 64/105, 61.0% females; 
≥18 weeks 34/78, 43.6% females; p=0.020).
Clinical data 
Clinical data were available for 154/183 cases 
(84.2%). Of these children, 141/154 (91.6%) 
were admitted and 13/154 (8.4%) were treated 
as ambulatory patients. Fifty-one hospitalised 
children (36.2%) required admission to a 
paediatric intensive care unit (PICU).
Hospital admission was associated with young 
age: 89/92 children <18 weeks of age (96.7%) 
required admission, whereas 52/62 children 
≥18 weeks of age (83.9%) required admission 
(p=0.005; RR 1.15; 95% CI 1.03 - 1.29).
PICU admission was also associated with 
young age: 45/89 children <18 weeks of 
age (50.6%) required intensive care v. 6/52 
≥18  weeks of age (11.5%) (RR 4.38; 95% 
CI 2.01 - 9.56; p<0.001).
The median hospital stay was 9.0 days 
(IQR 6 - 16.0, range 2 - 74). The median total 
duration of hospitalisation for children aged 
<18 weeks and ≥18 weeks was 10.0 and 8.0 
days, respectively (95% CI 1 - 5 days; p=0.006) 
(Table  3). Two children were excluded from this 
analysis as they had prolonged hospital stays 
(not PICU) due to other problems: one child 
required pneumonectomy for complications 
of concomitant pulmonary tuberculosis, and 
the other was newly diagnosed with congenital 
cyanotic heart disease.
It was difficult to ascertain from the clinical 
notes whether there were symptomatic 
contacts, but only 18/154 children (11.7%) 













































































































































Fig. 1. Number of cases of pertussis per month recorded in Bloemfontein and number of cases recorded 
by the NICD for the country, April 2008 ­ March 2015.




















77 120 136 326 206 141 241 12 1 259
Confirmed pertussis, 
Bloemfontein, n
12 6 22 96 13* 15 13 6 183
Confirmed pertussis, 
NICD data, n
60 25 74 374 274 156 163 46 1 172
*Underdiagnosis of cases in Bloemfontein due to laboratory problems during 2012.
Table 2. Age distribution of children 
diagnosed with pertussis (N=183)
Age group Cases, n (%)
0 - 28 days 9 (4.9)
29 - 42 days 21 (11.5)
43 - 70 days 37 (20.2)
71 - 98 days 27 (14.8)
99 days - <18 weeks 11 (6.0)
18 weeks - 18 months 60 (32.8)
≥19 months 18 (9.8)
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had a definite record of a coughing contact 
in the household.
Of the 139/154 children (90.3%) who 
presented with a cough, 110/137 (80.3%) had 
a cough lasting ≤7 days, 11/137 (8.0%) had 
a cough duration of 8 - 20 days and 16/137 
(11.7%) had a cough duration of ≥21 days. 
Other recorded symptoms compatible with 
classic pertussis included post-tussive vomiting 
in 60/154 cases (39.0%), cough paroxysms in 
23/154 (14.9%), convulsions in 24/154 (15.6%), 
apnoea in 22/154 (14.3%) and a whoop in 
7/154 (4.5%). Two of the 7 children with a 
whoop were <14 weeks of age, and the other 
5 were aged between 7 months and 4 years. 
All the infants presenting with apnoea, except 
one 10-month-old child who had chronic lung 
disease, were ≤12 weeks of age. Of the above 
symptoms, apnoea was significantly more 
common in children aged <18 weeks than in 
those aged ≥18 weeks (22.8% v. 1.6%; p<0.001).
Other symptoms, not classically recorded 
for pertussis, were noted: fever in 41/154 
(26.6%), diarrhoea in 23/154 (14.9%) and 
stridor or a croup syndrome in 6 (3.9%), 
while 10 (6.5%) presented with circulatory 
shock. Of these symptoms, fever was less 
common in children aged <18 weeks than 
in those aged ≥18 weeks (18.5% v. 38.7%; 
p=0.005). The most common comorbidities 
were malnutrition in 25/154 cases (16.2%), 
concomitant tuberculosis (microbiologically 
proven) in 11/154 (7.1%) and invasive pneu-
mococcal disease in 2/154 (1.3%). Children 
aged <18 weeks were less commonly mal-
nourished (7.6% v. 29.0%; p<0.001) and less 
commonly had tuberculosis (3.9% v. 12.9%; 
p=0.029) than those aged ≥18 weeks.
Full blood count results were available for 
144/154 children (93.5%). Total white cell 
counts (WCCs) ranged from 2.18 to 85.0 × 
109/L and in 58/144 cases (40.3%) were 
≥20.0 × 109/L. A lymphocyte predominance 
was found in 52/86 (60.5%) of children with 
a white cell count <20.0 × 109/L and in 27/58 
(46.6%) with a white cell count ≥20.0 × 109/L 
(p=0.100).
Twenty-two of the 154 children (14.3%) 
were HIV-infected, of whom 12 (54.5%) 
were already receiving antiretroviral therapy; 
91 (59.1%) were HIV-uninfected, and the 
HIV status was unknown or results were not 
available in 41 (26.6%). Among the children 
with known HIV status who were admitted 
Table 3. Comparison of duration of total hospital stay and PICU stay in children aged 
<18 weeks and ≥18 weeks
All ages <18 weeks ≥18 weeks p-value
Total hospitalisation days (incl. PICU) 
(N=139*)
0.006
Median 9 10.0 8.0
Mean 14.2 15.6 11.8
Range 2 - 74 2 - 74 2 - 67
Total PICU days (N=51) 0.155
Median 10.0 11.0 7.5
Mean 12.0 12.7 7.8
Range 3 - 43 3 - 43 3 - 13
*Two children were excluded from this analysis (see text).










Day of death 
after admission HIV status
Symptoms on 
admission
Morbidities associated with 
death





hyperviscosity syndrome, acute 
kidney injury, Escherichia coli 
sepsis, hypocalcaemia, raised 
transaminases










4 Sept 2011 10, F  <20.0 21 Exposed, 
uninfected
Cough 4 days Circulatory shock, anaemia, 
diarrhoea, hypoglycaemia
5 Oct 2011 27, F 37.5 12 Uninfected Convulsions, 
dyspnoea
Severe malnutrition with 
cellulitis of hand (surgical ward), 
possible nosocomial pertussis
6 Mar 2012 11, F <18.9 3 Uninfected Cough 5 days Pneumonia, respiratory 
failure, shock










M = male; F = female.
*All children were admitted directly to the PICU except for case 1, who was in the ward for the first 2 days, and case 5, who did not qualify for the PICU.
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to hospital, there was no statistical difference regarding rates of 
admission to the PICU between HIV-infected children (9/22, 40.9%) 
and those who were HIV-uninfected (36/88; 40.9%) (p=1.000). The 
median length of PICU stay was 14 days and 8.5 days in HIV-infected 
and HIV-uninfected children, respectively (p=0.101)
Outcomes of pertussis
Eight children (5.2%) died, 6 of whom had been admitted to a 
PICU; their ages ranged from 6 to 14 weeks, except for one who 
was 6 months old. Five children had very high WCCs (Table 4). Five 
children required readmission for ongoing illness. No data were 
available regarding duration of symptoms after discharge.
Discussion
This is the first reported hospital-based case series of children with 
pertussis in SA and highlights the significant morbidity and mortality 
associated with the disease. The last published report of pertussis in 
SA, an outbreak investigation, was from Cape Town in 1991.[3] What 
was initially thought to be an outbreak in Bloemfontein, noted by 
doctors in both the public and the private sector, has been shown 
to be an ongoing epidemic with a cyclical pattern, with the highest 
incidence of cases documented in the last quarter of 2011, both in 
Bloemfontein and nationally.[4] This peak in late 2011 and 2012 has 
also been documented in the UK.[5] It is not possible to comment on 
a seasonal trend, although the data over the 7 years show an increase 
of cases in autumn.
The Division of Public Health Surveillance and Response at the 
NICD has provided data on laboratory-confirmed pertussis cases 
available for the same time period for the whole country. It also 
includes data sent to the NICD from private sector laboratories. Of 
the total number of cases recorded by the NICD, 183/1 172 (15.6%) 
were identified in the public healthcare sector in Bloemfontein. 
This is a large proportion considering that according to the 2011 
census, the estimated population of the Mangaung metropolitan 
municipality (to which Bloemfontein belongs) made up 1.4% of the 
total population of SA.[6]
As expected, B. pertussis was the causative organism in most cases 
and B. parapertussis occurred in only a small number of cases. This 
has also been found in other studies.[7]
Table 2 shows that 105/183 children (57.4%) were aged <18 
weeks. This group represents infants who have not yet received the 
complete primary series of pertussis vaccine. The youngest children 
tended to have more severe disease, with most requiring hospital 
admission. Half of the infants <18 weeks of age required admission 
to the PICU. We did not have access to vaccine data for the children 
described in this case series, but would expect that, had vaccine 
coverage been optimal and timeous, this group of infants would 
probably have contributed a smaller proportion of the cases overall. 
Coverage of the third vaccine (DTP3 or DTP/Hib/polio/HepB3) at 
14 weeks has been recorded to be >90% in the Free State for some of 
the years (2007, 2008, 2011, 2012) included in this study.[8] A study 
in the Western Cape reported that <20% of second vaccinations, 
third combined vaccinations and the 18-month vaccination were 
given on time.[9] About one in 10 of the children diagnosed with 
pertussis was aged >18 months. If vaccine coverage was complete 
in this group, this would suggest that the vaccine effectiveness was 
not optimal.
The duration of hospital stay (median 9 days) was longer than that 
reported from a similar study in Switzerland (median 6 days), and 
this was more marked in infants <18 weeks of age. Infants admitted 
to the PICU also had a prolonged stay. Importantly, HIV infection did 
not influence the morbidity or length of stay of the infants. Morbidity 
is high in pertussis, and the mortality rate was 5.2% in this cohort.[10] 
The mortality for hospitalised children with lower respiratory tract 
disease at this site during the years of the study has been 4 - 5%.
 It is important to note that most children presented with a cough 
of <1 week’s duration, and some did not have a cough. The World 
Health Organization clinical case definition of pertussis requiring 
a cough of >2 weeks’ duration would underestimate the burden 
of pertussis in the absence of laboratory confirmation and may 
require revision.[11,12] Apnoea occurred mainly in young infants, but 
not exclusively. Of interest is that some children presented with a 
croup-like syndrome, and also with fever or diarrhoea. These are 
not usually described with pertussis. Some children had significant 
comorbidities (malnutrition, tuberculosis, other bacterial infections 
and HIV infection), which could obscure the diagnosis of pertussis.
Another classic pointer to the diagnosis of pertussis is a high white 
cell count.[11] In this group of children, 40.3% had a white cell count 
≥20.0 × 109/L, also found in more than half of the children who died. 
We did not have routine full blood count reports in many cases to 
enable us to comment on the presence of atypical lymphocytes.
Study limitations
This case series and the results provided by the NICD include only 
laboratory-confirmed pertussis cases. Bias from lack of clinical 
suspicion with no laboratory confirmation probably contributes to 
the underestimation of the burden of pertussis, both nationally and 
in this case series. Only patients who were ill enough to consult a 
medical doctor had a pertussis swab taken, and not every child with 
a respiratory complaint had a pertussis swab taken. There were no 
standard operating procedures in place regarding when pertussis 
swabs should be taken, and not every doctor was equally aware of the 
pertussis problem.
In 2012 the NHLS laboratory experienced problems with contamin-
ation and was unable to process some specimens, and several of these 
could not be repeated as the patients had been discharged. This may 
also have resulted in an under-recording of cases.
As the swabs were sent to Johannesburg for the PCR tests, we were 
notified of positive results 1 - 2 weeks after the swab had been taken 
and then retrieved the hospital records. The vaccination history of 
the children was not reliably recorded in the clinical notes, and some 
mothers did not have the child’s Road To Health book with them at 
the time of admission. We also could not obtain reliable figures of 
vaccination coverage in this area for these years, although figures 
for the Free State have been published by the Health Systems Trust 
for some of the years.[8] The pertussis problem reported in this study 
therefore cannot be evaluated in relation to vaccination coverage.
What the study contributes
The study shows the cycle of troughs and peaks of pertussis over a 
7-year period. This correlates with the data from the NICD and is a 
reasonable reflection of the pertussis problem that almost certainly 
has been occurring in the whole country but may have passed 
undiagnosed in many areas except for ‘sporadic’ cases which were 
reported in the NICD communiques.[13-16] This study shows the ‘tip of 
the ears of the hippopotamus’, and the burden of pertussis is probably 
much larger than what this case series has documented. The burden 
of disease is carried by young infants, who have a prolonged hospital 
stay and a high rate of PICU admission.
Recommendations
To plan rational interventions, surveillance for pertussis needs to 
improve, not only among children but also among adolescents and 
adults. Data from other countries indicate that adolescents and adults 
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do get pertussis and act as reservoirs for transmission to infants and 
children.
Maternal vaccination at the beginning of the third trimester of 
pregnancy is being implemented in many countries to reduce the 
burden of pertussis in early infancy. This is certainly an attractive 
option and has been shown to be cost-effective. Vaccination of 
mothers (postnatal) and other household members (cocooning) is 
another possible, but less effective, intervention. These immunisation 
measures would protect the young infant, who is most at risk of 
developing severe pertussis disease.[17,18] Consideration should also be 
given to vaccination of healthcare workers, especially those working 
with infants.[19]
Conclusions
This case series of pertussis in Bloemfontein shows the cyclical 
pattern of the disease over 7 years with pronounced outbreak activity 
in 2011 through 2012, and documents a large proportion of the 
country’s total number of diagnosed cases. Many children did not 
have a cough of at least 2 weeks’ duration. Young infants were most 
severely affected, requiring prolonged hospital stay with a large 
percentage requiring PICU admission.
Author contributions. UMH conceived and developed the study, wrote 
the study protocol, collected the clinical data, participated in data analysis, 
interpreted the results, and wrote and checked the final manuscript. GJ 
contributed to the study protocol, undertook the data analysis, contributed 
to the interpretation of results and contributed to and checked the final 
manuscript. YG contributed to the study protocol, collated the data and 
checked the final manuscript.
Funding. No external funding was required for the study. All investigations 
were part of routine case management. 
Acknowledgements. We acknowledge the following for their contributions 
to the case series of this 7-year period: (i) doctors who suspected pertussis, 
for taking swabs for pertussis PCR testing to confirm the diagnosis; (ii) 
for advice and regularly emailing results to the first author (UH) over 
the years: E Elliott, M Pieters (Department of Medical Microbiology, 
University of the Free State and NHLS, Bloemfontein), and medical 
scientists at NHLS, Infection Control Services, Johannesburg (L Blann, 
V Mohlabine, K le Roux, D Schnugh); (iii) J Thomas and G Ntshoe of the 
NICD for providing the monthly case numbers of laboratory-confirmed 
pertussis cases for SA; (iv) the clinical managers of Pelonomi, National 
District and Universitas hospitals for permission to collect the data; and 
(v) G Hussey for encouragement and advice with the manuscript.
 
1. Mulholland K. Measles and pertussis in developing countries with good vaccine coverage. Lancet 
1995;345(8945):305-307. DOI:10.1016/S0140-6736 (95) 90282-1
2. Mooi FR, van der Maas NAT, de Melker HE. Pertussis resurgence: Waning immunity and pathogen 
adaptation – two sides of the same coin. Epidemiol Infect 2014;142(4):685-694. DOI:10.1017/
S0950268813000071
3. Strebel P, Hussey G, Metcalf C, Smith D, Hanslo D, Simpson J. An outbreak of whooping cough in 
a highly vaccinated urban community. J Trop Pediatr 1991;37(2):71-76. DOI:10.1093/tropej/37.2.71
4. Hallbauer UM, Goosen Y, Pieters M. An outbreak of pertussis in Bloemfontein, South Africa, 2008-
2009. S Afr Fam Pract 2011;53(5):495-500. DOI:10.1080/20786204.2011.10874140
5. Forsyth K, Plotkin S, Tan T, Wirsing von König C. Strategies to decrease pertussis transmission to 
infants. Pediatrics 2015;135(6):e1475-1482. DOI:10.1542/peds.2014-3925
6. Statistics South Africa. Census 2011 Statistical Release – P0301.4/Statistics South Africa. Pretoria: SSA, 
2012. http://www.statssa.gov.za/publications/P03014/P030142011.pdf (accessed 9 July 2015)
7. Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin RD, Cherry JD, Demmler GJ, 
Kaplan SL, eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia: Saunders, 2004:1588-1608.
8. Health Systems Trust. DTP3 coverage. http://indicators.hst.org.za/healthstats/297/data (accessed 16 July 2015).
9. Corrigall J, Coetzee D, Cameron N. Is the Western Cape at risk of an outbreak of preventable 
childhood diseases? Lessons from an evaluation of routine childhood immunisation coverage. S Afr 
Med J 2008;98(1):41-45.
10. Heininger U, Weibel D, Richard J-L. Prospective nationwide surveillance of hospitalizations due 
to pertussis in children, 2006-2010. Pediatr Infect Dis J 2014;33(2):147-151. DOI:10.1097/01.
inf.0000435503.44620.74
11. Cherry JD, Tan T, Wirsing von König C, et al. Clinical definition of pertussis: Summary of a Global 
Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis 2012;54(12):1756-1764. 
DOI:10.1093/cid/cis302
12. Shakib J, Wyman L, Gesteland PH, et al. Should the pertussis case definition for public health reporting 
be refined? J Public Health Manag Pract 2009;15(6):479-484. DOI:10.1097/PHH.0b013e3181af0ac3
13. National Institute for Communicable Diseases, Division of the National Health Laboratory Service. 
Pertussis cluster. Communicable Diseases Communiqué 2009;8(2):3-4. http://www.nicd.ac.za/assets/
files/NICDCommFeb09Vol08_02.pdf (accessed 22 September 2015)
14. National Institute for Communicable Diseases, Division of the National Health Laboratory Service. 
Pertussis. Communicable Diseases Communiqué 2010;9(8):4-5.
15. National Institute for Communicable Diseases, Division of the National Health Laboratory Service. 
Pertussis. Communicable Diseases Communiqué 2011;10(2):1-2 http://www.nicd.ac.za/assets/files/
NICD%20Communique%20February%202011(1).pdf (accessed 22 September 2015).
16. National Institute for Communicable Diseases, Division of the National Health Laboratory Service. Pertussis. 
Communicable Diseases Communiqué 2015;14(6):4-6 http://www.nicd.ac.za/assets/files/NICD-NHLS%20
Communicable%20Disease%20Communiqu%C3%A9_June%202015.pdf (accessed 22 September 2015).
17. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, 
and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 
2013;56(4):539-544. DOI:10.1093/cid/cis923
18. Lugnér AK, van der Maas N, van Boven M, Mooi FR, de Melker HE. Cost-effectiveness of targeted 
vaccination to protect new-borns against pertussis: Comparing neonatal, maternal, and cocooning 
vaccination strategies. Vaccine 2013;31(46):5392-5397. DOI:10.1016/j.vaccine.2013.09.028
19. Heininger U. Vaccination of health care workers against pertussis: Meeting the need for safety within 
hospitals. Vaccine 2014;32(38):4840-4843. DOI:10.1016/j.vaccine.2013.10.062
Accepted 18 April 2016.
